In Brief: Cygnus
This article was originally published in The Tan Sheet
Executive Summary
Cygnus: Nicotrol sales rise to $5.6 mil. in the second quarter, the firm notes. The sales figure includes U.S. and European product sales and royalties from McNeil Consumer Products, which licenses the smoking cessation transdermal patch. Cygnus increased shipments of Nicotrol in the quarter in anticipation of FDA's July 3 approval of the Rx-to-OTC switch ("The Tan Sheet" July 8, p. 1)...